Intravenous amantadine sulphate application improves the performance of complex but not simple motor tasks in patients with Parkinson's disease
- 31 January 2003
- journal article
- research article
- Published by Elsevier BV in Neuroscience Letters
- Vol. 339 (1), 25-28
- https://doi.org/10.1016/s0304-3940(02)01462-3
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Attentional deficits in Alzheimer's, Parkinson's, and Huntington's diseasesActa Neurologica Scandinavica, 2009
- Tapping and Peg Insertion after Levodopa Intake in Treated and de novo Parkinsonian PatientsCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2002
- Correlation between Tapping and Inserting of Pegs in Parkinson's DiseaseCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2000
- Transient benefit of amantadine in Parkinson's disease: The facts about the mythMovement Disorders, 1999
- 2-[123I]-Iodolisuride SPET visualizes dopaminergic loss in de-novo Parkinsonian patientsNuclear Medicine Communications, 1997
- Amantadine in advanced Parkinson's disease: good use of an old drug.Zeitschrift für Neurologie, 1997
- The Neurobiological Basis of Movement InitiationProgress in Neurobiology, 1997
- Therapeutic brain concentration of the NMDA receptor antagonist amantadineNeuropharmacology, 1995
- Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Cognitive function in Parkinson's disease: From description to theoryTrends in Neurosciences, 1990